• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Fierce London event panel
Biotech

Big Pharmas tell Fierce's London event about their ideal biotech

Dealmakers for five of the biggest pharmas shared the stage at Fierce's event in London to debate what they look for in an ideal biotech partner.
Ben Adams Nov 18, 2026 5:18am
Fierce panel London

Fierce’s London event told it could be ‘Europe’s year to shine’

Nov 17, 2026 10:00am
Brain scan neuroscience

Priavoid’s Alzheimer’s pill fails to prove efficacy in ph. 2

Nov 18, 2026 4:21am
merck

Merck axes $2.7B BTK inhibitor program after seeing ph. 3 data

Nov 18, 2026 3:11am
Heidi Overton at HELP committee nomination hearing
Favicon Fierce Pharma

Overton’s FDA nomination pulled by White House: reports

Nov 17, 2026 9:15pm
FDA
Favicon Fierce Pharma

FDA slams China-heavy data in Summit’s ivonescimab CRL

Nov 17, 2026 4:48pm
More News

A ‘very detailed map’ of enzyme target in rare genetic disease

Nov 17, 2026 3:31pm

Kyntra drops mid-stage ADC, adding to years of stumbles

Nov 17, 2026 10:40am

Isomorphic Labs raises $5B series C months after $2.1B round

Nov 17, 2026 9:20am
Fierce Pharma

AriBio’s oral Alzheimer’s drug meets monotherapy goal in ph. 3

Nov 17, 2026 7:43am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings